When we further explored the frequency and timing of CYLD mutations, we found that there were only 12 timed driver mutations of CYLD across all primary cancers (4 early, 8 late), whereas there were 98 across metastatic tumours (6 early, 92 late). Here, CYLD is linked to metastatic neoplasm.